mometasone fuorate (LYR-210) / Lyra Therap 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
4 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
mometasone fuorate (LYR-210) / Lyra Therap
2021-005906-83: Efficacy, Safety, Tolerability Study of LYR-210 Depot in Chronic Sinusitis Studie účinnosti, bezpečnosti a snášenlivosti přípravku LYR-210 u chronické sinusitidy

Not yet recruiting
3
180
RoW, Europe
LYR-210, LYR-210, Implant
Lyra Therapeutics, Inc., Lyra Therapeutics, Inc.
Chronic Rhinosinusitis (CRS) in Adults, Chronic Rhinosinusitis (CRS) in Adults, Diseases [C] - Bacterial Infections and Mycoses [C01]
 
 
ENLIGHTEN 1, NCT05219968: Efficacy and Safety of LYR-210 for the Treatment of Chronic Rhinosinusitis in Adults

Active, not recruiting
3
196
Europe, US, RoW
LYR-210, Sham procedure control, Background Therapy
Lyra Therapeutics
Chronic Sinusitis, Chronic Rhinosinusitis (Diagnosis)
03/24
09/24
ENLIGHTEN 2, NCT05295459 / 2021-006911-27: Efficacy and Safety of LYR-210 for the Treatment of Chronic Rhinosinusitis in Adults

Recruiting
3
180
Europe, US
LYR-210, Sham procedure control, Background therapy
Lyra Therapeutics
Chronic Sinusitis, Chronic Rhinosinusitis (Diagnosis)
12/24
12/24
2018-004621-89: Efficacy, Safety, Tolerability Study of LYR-210 Depot in Chronic Sinusitis

Not yet recruiting
2
110
RoW, Europe
LYR-210, Implant
Lyra Therapeutics, Inc., Lyra Therapeutics, Inc.
Chronic sinusitis, Chronic sinusitis, Diseases [C] - Bacterial Infections and Mycoses [C01]
 
 

Download Options